A new Commentary in Brain (@brain1878.bsky.social) ‘Timing the Alzheimer’s disease pathological cascade’ by Wiesje Pelkmans (@wiesjepelkmans.bsky.social), Vasiliki Bikou and Gemma Salvadó (@gsalvado.bsky.social) 👇 academic.oup.com/brain/advanc...
Barcelonaβeta Brain Research Center
@barcelonabeta.bsky.social
Research centre of @fpmaragall.bsky.social, pioneer in the study and prevention of Alzheimer's and other neurodegenerative diseases.
Can blood biomarkers improve dementia diagnosis? A new study co-led by Dr. Marta del Campo, together with Dr. Giovanni Bellomo and Charlotte Teunissen, developed a quantitative biomarker panel that helps differentiate between the main neurodegenerative diseases that cause dementia.
🧬 Why do genetic variants that increase disease risk persist through evolution? A study published in @natecoevo.nature.com, led by @ibe-barcelona.bsky.social and involving the BBRC with Dr. Arcadi Navarro as corresponding co-author, provides new answers. www.barcelonabeta.org/en/news/news...
And just like that, #AAIC26 is over! The global #Alzheimer's research community gathered in London to share knowledge and drive science forward — and this year, the BBRC and @fpmaragall.bsky.social showed up with our largest participation at the congress so far. 🧠 @alzassociation.bsky.social
📍 #AAICForAll is here — Dr. @marcsuarezcalvet.bsky.social is taking part in the AAIC For All: Clinicians session today! Dr. Marc Suárez-Calvet presented at the session "Clinical Practice Guideline: Blood Biomarkers In Alzheimer's Disease". Really interesting insights! 👏 #AAICForAllClinicians
📍 Day 4 at #AAIC26: final day of #BBRC contributions! Take a look at today's programme ⤵️ @alzassociation.bsky.social @gsalvado.bsky.social @gerardts9.bsky.social @clara-gallay.bsky.social @nuuria8.bsky.social
📍 Day 3 at #AAIC26 — great science doesn't stop! Check out today's contributions ⤵️ @alzassociation.bsky.social @istaart.bsky.social @marcsuarezcalvet.bsky.social
🧠 Day 2 at #AAIC26 is here, and we have a full day ahead! Here's today's schedule, starting with the presentations from 2 #BBRC researchers ⤵️ @alzassociation.bsky.social @istaart.bsky.social @fpmaragall.bsky.social
🧠🏆 Ending the 1st day of #AAIC26 on a high note! Congratulations to Dr. @gsalvado.bsky.social, Dr. Laia Montoliu-Gaya and co-authors: their paper on plasma tau biomarkers has received the 2025 Publication of the Year Award from the @istaart.bsky.social BBB PIA.
Don’t miss out tomorrow the @clara-gallay.bsky.social poster showing her new preliminary results of her research line of pregnancy and AD risk 🧠❤️ #AAIC2026 @alzassociation.bsky.social @barcelonabeta.bsky.social
🧠 Day 1 at #AAIC26 is officially underway! Have a look at today’s schedule!! ⤵️ @alzassociation.bsky.social @istaart.bsky.social @fhernandezv.bsky.social @wiesjepelkmans.bsky.social
🌟Today marked the opening of our AD-RIDDLE General Assembly Meeting hosted by @barcelonabeta.bsky.social, where consortium members came together to share progress, exchange ideas and strengthen collaboration. 💥 We had an amazing first day and are looking forward to Day 2! @ihieurope.bsky.social
Getting early start at #AAIC26? Join us at the Preconference Workshop: Mastering Fluid Biomarkers to Unlock the Secrets of Alzheimer's Disease. 📅 July 10 | 🕗 8AM - 5PM 📍 Peninsula East – InterContinental-The O2 With the participation of Dr. @fanastasi.bsky.social as speaker #AAIC2026
Going to #AAIC26 in London? Let’s meet! 👋 Join our business suite for exclusive meetings: we’re looking to catch up with long-standing partners and explore new collaborations in London. Book a slot to meet our team here 👇 🔗 forms.office.com/e/wNygtqhBck #ScientificCollaboration
So happy to host the @ad-riddle.bsky.social General Assembly! Nice to see you all in person and be able to see what we have achieved so far and discuss next steps 🙌
AD-RIDDLE@ad-riddle.bsky.social · 4w ago📢 Today marks the start of our General Assembly, kindly hosted by @barcelonabeta.bsky.social. Together with partners, we're gathering to strengthen our collaboration and advance our shared mission to revolutionise the prevention, detection & treatment of Alzheimer's disease @ihieurope.bsky.social
🚶 Walking the Talk for Dementia brought together researchers, people living with dementia, caregivers and volunteers for a unique initiative combining four days on the Camino de Santiago with a scientific symposium in Santiago de Compostela.
Behind every breakthrough, there's a brain scan. 🧠 This year, our MRI facility reached an important milestone: 10,000 MRI scans performed in support of Alzheimer's research. Read more: www.barcelonabeta.org/en/news/news... Here's why this matters. 👇
The image of a decade: 10,000 MRI scans to understand Alzheimer’s at the BBRC
The BBRC reaches a historic milestone that reflects years of collective effort, cutting-edge technology and an open, collaborative science model.
barcelonabeta.org
📣 We're heading back to #AAIC26, the world's largest Alzheimer's research conference, taking place this year in London from July 12–15. 🔗 www.barcelonabeta.org/en/news/news... @alzassociation.bsky.social
🧠 Yesterday, @gsalvado.bsky.social, leader of the #BBRC Neuroimaging Research Group, took center stage at the International Conference of Brain Energy Metabolism (ICBEM 2026), presenting the ALFA Study and highlighting the research carried out at #BBRC @fpmaragall.bsky.social. 👏
🧠The Barcelonaβeta Brain Research Center strengthens its research in molecular epidemiology and data science with a new group led by Dr Natàlia Vilor-Tejedor. This reinforces BBRC’s strategy in Alzheimer’s research and consolidates the center’s capacity to nine research groups.
1/ 🧠💡 Una mala higiene del sueño puede llevar a padecer una privación de este, afectando a la salud. Sigue estos “tips” de la Dra. @anafdezarcos.bsky.social (@barcelonabeta.bsky.social @fpmaragall.bsky.social) para cuidar tu sueño y tu cerebro. 🧵👇
New study! #Alzheimer's affects women disproportionately, 2 in every 3 diagnoses. Pregnancy causes profound hormonal and brain changes, including in the hippocampus. Could reproductive history shape the disease's earliest stages? www.barcelonabeta.org/en/news/news...
We analyze the relationship between the reproductive history and the preclinical stages of Alzheimer’s disease
The study provides preliminary evidence that the number of births may only influence cognitive decline in women who already have high levels of β-amyloid protein in their brain
barcelonabeta.org
🧠 A new BBRC-led study published in @ebiomedicine.bsky.social shows that blood biomarkers may help rule out Alzheimer’s disease pathology in people with subjective memory complaints. This could support earlier & accessible clinical decision-making in people with subjective cognitive decline.
🧠 Biomarkers are shaping the future of Alzheimer’s research. At the 8th #BiomarkersCourse, co-organised by the #BBRC, @ucl.ac.uk and Univ. of Gothenburg, nearly 100 researchers and 20+ experts gathered in Barcelona to discuss the latest advances in the field. 🔗 www.barcelonabeta.org/en/news/news...
Biomarkers consolidate their key role in the future of Alzheimer’s and neurodegenerative disease research
Around 100 researchers have taken part in a new edition of the Biomarkers Course organized by BBRC together with the University College London and the University of Gothenburg.
barcelonabeta.org
The #BiomarkersCourse concludes its 8th edition with prizes and final remarks. Five days of scientific exchange, training and discussion on biomarkers in neurodegenerative diseases. A moment to recognise participants’ work and the collaborative spirit of the course.
🧠 The final day continues with project presentations, showcasing the work developed throughout the course.
Day 5️⃣ of the #BiomarkersCourse brings the course to its final day, with the closing session and project presentations. A moment to bring together five days of training, discussion and scientific exchange.
Day 4️⃣ of the #BiomarkersCourse continues in the afternoon with sessions on PET imaging of inflammation and #Alzheimer’s disease treatment strategies.
Day 4️⃣ of the #BiomarkersCourse focuses on PET imaging approaches in neurodegenerative disease research.
